Roche’s Tecentriq-based melanoma combos leapfrog into pivotal trials after promising PhIb results

Roche's Tecentriq-based melanoma combos leapfrog into pivotal trials after promising PhIb results tracy Mon, 11/07/2016 - 09:14…
Read the full story: Feed